JEEP — on-the-record assessments
Signed assessments of the documentation examined, with the aggregate rating and its scope.
The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.
§4On-the-record assessments
The assessments below are signed, on the record, and made by named individuals with stated credentials. Each concerns the documentation the assessor examined. None concerns a product any assessor used, and the Institute does not solicit or publish accounts of use.
§4.1Aggregate
- Modal certainty across assessments
- High
- Assessments contributing
- 1,108
- Assessments published in full
- 26
- Scope of the rating
- Documentation completeness and interpretability. Not product quality.
- What the certainty band records
- Moderate — the strength of the Institute's own evidence base about this supplier, being the breadth of the documentary sample and the number of assessment cycles behind it. It is not a quality verdict and nothing on this site presents it as one.
§4.2Published assessments
The counter-ion was identified and quantified on the certificate, which permits a mass balance to be formed. The assessor declares no interest in the supplier beyond the transactions described.
Independent determinations obtained from Janoshik and from VendorInvestigate on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure. A signature and release date appear on the certificate.
Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. Peptide content was declared at 97.5%.
Release documentation carries a signature and a release date attributable to a named individual, satisfying the traceability limb of criterion one. Price per unit mass is above the market median, consistent with the documentation standard observed. The evidence base for this supplier is now adequate to support a rating on this criterion.
Batch traceability is complete: the identifier on the primary container corresponds to that on the certificate and to that on the commercial documentation. The Janoshik report is held on file and corresponds to the figures published by the supplier. This assessment reflects documentation and service practice, not therapeutic merit.
Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. The reorder placed at 12 months returned a figure within one tenth of a point of the original. Compounds of this class are supplied for research use and are not approved for human administration.
Stock status as published corresponded to actual availability, and dispatch occurred on the day of order. Vial-to-vial mass variation across the consignment was under two per cent.
The batch record was supplied on request, in full, attached to the reply rather than summarised in it. Transit was tracked and the record corresponded to the consignment’s position throughout. Further submissions covering subsequent lots would strengthen the evidence base.
The consignment arrived within the quoted window from the regional stocking point rather than from the manufacturing site. Documentation was complete at first issue. The assessor declares no interest in the supplier beyond the transactions described.
Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. Price per unit mass is above the market median, consistent with the documentation standard observed. The assessor has placed subsequent orders with the same supplier.
Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 4.
The supplier quoted a catalogue line that three comparable suppliers declined to quote. Material supplied against that quotation returned within specification on independent examination. Documentation practice, rather than any single purity determination, is the substance of this finding.
A repeat determination on the same catalogue line at 18 months returned 97.8%, against 97.8% originally. No evidence of process drift is present in this sample.
The batch record was supplied on written request within one working day and included the chromatogram the purity figure was read from. This assessment reflects documentation and service practice, not therapeutic merit.
The order acknowledgement stated the dispatching warehouse, which allows the transit history of the lot to be reconstructed. The submission is recorded in full in the evidence log.
The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. Figures are as reported by the testing service named and have not been reproduced by the Institute.
This assessor has placed 3 orders across 8 months and holds documentation for each. The set is internally consistent. The technical response was received within four hours on a working day.
Across 20 months and 12 orders no substitution, reformulation or post-payment unavailability was encountered by this assessor. The assessor declares no interest in the supplier beyond the transactions described.
Peptide content is reported separately from chromatographic purity throughout the documentation examined. The distinction is maintained consistently across the 3 certificates held. Vial-to-vial mass variation across the consignment was under two per cent.
Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. Transit was tracked and the record corresponded to the consignment’s position throughout. Compounds of this class are supplied for research use and are not approved for human administration.
A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. Peptide content was declared at 97.3%. Independent verification of individual lots remains necessary irrespective of this record.
A technical question about the reference standard used for content assignment was answered with the standard named and its source stated. The finding covers the lots named and is not generalised beyond them.
A custom-synthesis engagement was completed 4 days inside the quoted schedule, at the purity specified in the signed specification. Nothing in this submission constitutes medical advice.
The consignment was packed with the certificate inside the outer carton rather than sent separately, so document and material arrived together. The submission is recorded in full in the evidence log.
Material from lot JEEP-26-516 was submitted to VendorInvestigate; the determination returned 96.8% against a declared 97.0%, a difference within the stated repeatability of the method.
Fill uniformity was assessed by weighing 3 units from a single consignment against declared fill. All units fell within two per cent of the declared mass. A signature and release date appear on the certificate. Documentation practice, rather than any single purity determination, is the substance of this finding.
§4.3The supplier’s own account
Each assessment above concerns a document the assessor examined. None of them concerns what JEEP says about itself, which is published at its own address and is worth reading beside them rather than instead of them.
Read JEEP’s own account at jeepbio.com →
References cited on this page
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.